407
Participants
Start Date
May 10, 2021
Primary Completion Date
November 18, 2021
Study Completion Date
January 27, 2022
ensovibep
IV on day 1 only.
Placebo
IV on day 1 only.
Jongaie Research, Pretoria
Clinresco Centres (Pty) Ltd, Kempton Park
DJW Navorsing, Krugersdorp
Wits Clinical Research, Soweto
Sandton Medical Research Centre, Sandton
Debreceni Egyetem, Debrecen
Enhancing Care Foundation, Durban
George Provincial Hospital, George
Dr JM Engelbrecht Trial Site, Somerset West
FARMOVS (Pty) Ltd, Bloemfontein
Centennial Medical Group - Research Department, Elkridge
Monroe Biomedical Research, Monroe
Wilmington Health, Wilmington
VitaLink Research, Greenville
Clinical Research of Rock Hill, Rock Hill
Gwinnett Research Institute, Buford
IACT Health, Columbus
Panax Clinical Research, LLC, Miami Lakes
Boward Infectious Disease and Primary Care, Margate
Suncoast Research Group, LLC, Miami
Life Spring Research Foundation, Miami
Bio-Medical Research, LLC, Miami
Palm Beach Research Center, West Palm Beach
AdventHealth Tampa, Tampa
Jasper Summit Research, LLC, Jasper
Great Lakes Clinical Trials, Chicago
Jefferson City Medical Group, Jefferson City
Epic Medical Research, Red Oak
Fairway Medical Clinic, Houston
1960 Family Practice, PA, Houston
Zion Urgent Care Clinic, Katy
Family Practice Center, McAllen
Future Innovative Treatments, Colorado Springs
Providence Family Medical Center, Redondo Beach
Benchmark Southern California, Colton
Pacific Neuropsychiatric Specialists, Mission Viejo
Ascada Research, Fullerton
BAPS Pramukhswami Hospital, Surat
Grant Medical College & Sir J. J. Group of Hospitals, Mumbai
Government Medical College, Aurangabad
Government Medical College and Hospital, Nagpur
All India Institute of Medical Sciences - Nagpur, Nagpur
St. Theresa's Hospital, Hyderabad
Durgabai Deshmukh Hospital & Research Centre, Vidyānagar
King George Hospital, Visakhapatnam
Shetty's Hospital, Bengaluru
VHS-Infectious Disease Medical Centre, Chennai
UMC Utrecht, Utrecht
Lead Sponsor
Collaborators (1)
Molecular Partners AG
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY